Literature DB >> 15034105

Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: a prospective ten-year follow-up.

Robert W Schrier1, Mark M Belz, Ann M Johnson, William D Kaehny, Richard L Hughes, David Rubinstein, Patricia A Gabow.   

Abstract

Patients with autosomal dominant polycystic kidney disease (ADPKD) have a higher incidence of intracranial aneurysms (ICA) than the general population. These ICA also rupture at an earlier age in patients with ADPKD and are associated with high morbidity and mortality. In a recent study, 25% of patients with ADPKD with a documented ICA demonstrated a new ICA on follow-up. It is not known, however, whether patients with ADPKD who have had a negative ICA imaging study would demonstrate an ICA on a repeat imaging study. Only 2 (2.6%) of 76 patients with ADPKD with an initially negative study demonstrated an ICA on follow-up, despite the high frequency of risk factors such as hypertension, smoking, and a family history of ruptured ICA. The mean length of follow-up was 9.8 yr (median, 9.7 yr). These findings have important health care and economic implications in following patients with ADPKD.

Entities:  

Mesh:

Year:  2004        PMID: 15034105     DOI: 10.1097/01.asn.0000118527.74850.66

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  14 in total

Review 1.  Diagnosis and management of childhood polycystic kidney disease.

Authors:  William E Sweeney; Ellis D Avner
Journal:  Pediatr Nephrol       Date:  2010-10-29       Impact factor: 3.714

2.  Presymptomatic Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Irina M Sanchis; Shehbaz Shukoor; Maria V Irazabal; Charles D Madsen; Fouad T Chebib; Marie C Hogan; Ziad El-Zoghby; Peter C Harris; John Huston; Robert D Brown; Vicente E Torres
Journal:  Clin J Am Soc Nephrol       Date:  2019-07-30       Impact factor: 8.237

3.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

Review 4.  Should patients with autosomal dominant polycystic kidney disease be screened for cerebral aneurysms?

Authors:  M N Rozenfeld; S A Ansari; A Shaibani; E J Russell; P Mohan; M C Hurley
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-04       Impact factor: 3.825

Review 5.  Renal transplantation in autosomal dominant polycystic kidney disease.

Authors:  Nada Kanaan; Olivier Devuyst; Yves Pirson
Journal:  Nat Rev Nephrol       Date:  2014-06-17       Impact factor: 28.314

Review 6.  Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.

Authors:  Tevfik Ecder; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

Review 7.  The spectrum of autosomal dominant polycystic kidney disease in children and adolescents.

Authors:  Bharathi V Reddy; Arlene B Chapman
Journal:  Pediatr Nephrol       Date:  2016-03-31       Impact factor: 3.714

8.  Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.

Authors:  Jin Ah Kim; Jon D Blumenfeld; Shalini Chhabra; Silvina P Dutruel; Nanda Deepa Thimmappa; Warren O Bobb; Stephanie Donahue; Hanna E Rennert; Adrian Y Tan; Ashley E Giambrone; Martin R Prince
Journal:  Radiology       Date:  2016-04-05       Impact factor: 11.105

Review 9.  Renal relevant radiology: radiologic imaging in autosomal dominant polycystic kidney disease.

Authors:  Frederic Rahbari-Oskoui; Ankush Mittal; Pardeep Mittal; Arlene Chapman
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-26       Impact factor: 8.237

Review 10.  Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD.

Authors:  Dana Rizk; Arlene Chapman
Journal:  Pediatr Nephrol       Date:  2008-02-08       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.